Delivery Order SPE2DB22D2006-SPE2DB23FV9MF
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,999.46 firm fixed-price delivery order is for the supply of 4568250414 - INFUVITE ADULT VIAL 10ML, with a performance period through May 15, 2025. The contract is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,499.73 firm fixed-price delivery order is for the supply of Infuvite Adult Vial 10ML, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,000.10 firm fixed-price delivery order is for the supply of INFUVITE ADULT VIAL 10ML, a medical product, with a completion date of May 16, 2025. The contract is not set aside and represents an individual delivery order under Amerisourcebergen's broader $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award, with a ceiling value of $2,522.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of INFUVITE ADULT VIAL 10ML medical supplies, with an ultimate completion date of November 17, 2023. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for Amerisourcebergen to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $59,659.19 firm fixed-price delivery order is for the supply of INFUVITE ADULT VIAL 10ML medical products, with a performance period ending on May 16, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,375.24, is for the delivery of INFUVITE ADULT VIAL 10ML medical products. It is a firm fixed-price contract with an ultimate completion date of April 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of INFUVITE ADULT VIAL 10ML, a medical product, with a ceiling value of $6,413.18 and a period of performance through April 30, 2025. This contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of INFUVITE ADULT BULK VIAL 100ML medical supplies. The $5,075.04 firm-fixed-price delivery order falls under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of INFUVITE ADULT VIAL 10ML, a medical product, with a ceiling value of $4,999.10. The contract is a firm-fixed price, non-set-aside delivery order with a performance period ending on May 14, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company, to provide a 10 ml vial of the medication INFUVITE ADULT. The contract has a completion date of February 5, 2024 and a potential value of $3,007.93. This order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB23FV9MFDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,126.15 Firm Fixed Price delivery order contract is for the supply of INFUVITE ADULT VIAL 10ML medical products. The contract has an ultimate completion date of May 2, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This delivery order is issued under that overarching IDC contract. No set-aside designation was used for this specific award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/1/23 |